This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
With radiopharmaceuticals emerging as a diagnostic and therapeutic (theranostics) procedure, many are in the clinicaldevelopment pipeline and are expected to play a crucial role in the future of healthcare. The goal is to deliver a precise radiation dose to the diseased tissues while minimizing damage to surrounding healthy tissue.
At its annual Pharma Media Day 2022, Bayer presented the latest developments in the ongoing transformation of its pharmaceuticals business, which is aimed at delivering long-term, sustainable business growth by bringing forward new options for patients. “We Re-imagining Radiology.
The companies acquired by Bayer, Noria and PSMA Therapeutics, have exclusive world-wide rights to technology licensed from Weill Cornell Medicine (New York, NY, USA) and Johns Hopkins University (Baltimore, MD, USA). Noria was founded by Dr. John Babich, Chief, Radiopharmaceutical Sciences in Radiology at Weill Cornell Medicine.
Might is director of the Hugh Kaul Precision Medicine Institute and Professor of both Internal Medicine and Computer Science at the University of Alabama at Birmingham. Previously, Baffa was Therapeutic Area Head of Oncology, Global ClinicalDevelopment for Shire.
The platform already has potentially ground-breaking medical innovations in clinicaldevelopment, such as a therapy for the treatment of Parkinson’s. Sales of prescription medicines (Pharmaceuticals) rose by 16.2 Group sales in the second quarter increased by 12.9 Pharmaceuticals raises sales and earnings.
The discourse wasn’t just about cycling through tissue or aiding clinicaldevelopment; it ranged from mutation prediction to tumor microenvironment (TME) analysis to how AI can aid in diagnosis and treatment planning to achieve better outcomes for patients. Anne Marie, any insights into the unique trends at ESMO 2024?
Radiobiological and Clinical Considerations from CRO and Emerging Biotech Radiopharmaceuticals are medicinal formulations containing radioisotopes that are used in the field of nuclear medicine primarily for the diagnosis and treatment of various diseases, particularly cancer. There have been more than $1.7
It is characterized by progressive fibrosis, lung scarring, and a radiological pattern known as usual interstitial pneumonia, or UIP. National Library of Medicine at the National Institutes of Health, about 100,000 people are affected in the United States , and 30,000 to 40,000 new cases are diagnosed each year. According to the U.S.
“Failure to study medications and other interventions in a broad sampling has led to women experiencing adverse effects from medications at nearly twice the rate of men ,” says Dr. Jaclyn Jansen, MD, MS, Medical Director of the Medical Department, General Medicine, Medpace. Precision medicine benefits breast cancer treatment.
Symptoms may include hypoxia, cough, dyspnea, or interstitial infiltrates on radiologic exams. Dose interruption or dose reduction is recommended in patients who develop persistent or recurrent Grade 2 ILD/pneumonitis. Across the clinicaldevelopment program, deaths due to venous thromboembolism have been reported.
4-6 New data from Washington University School of Medicine demonstrated Evusheld retained potent neutralising activity against the emerging and highly transmissible BA.2 4-6 New data from Washington University School of Medicine demonstrated Evusheld retained potent neutralising activity against the emerging and highly transmissible BA.2
How the FDA’s ‘master plan’ will affect NIH funding for digital medicine projects ( STAT ).
ICH plots major overhaul of good clinical practice guideline ( Endpoints ).
Sandoz confirms late-stage clinicaldevelopment plans for proposed biosimilar aflibercept, a key ophthalmology medicine ( Press ).
President Jair Bolsonara recently admitted that he, too has tested positive for COVID-19 and he, like Trump, believes in the medicinal power of hydroxychloroquine, despite good evidence to the contrary. Below are some free webinars you can register for that have delved into the topic: Continuing Clinical Research Innovations After COVID-19.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content